|Last Price$45.27||Day Change (%)0.18%|
|Open Price$45.33||Day Change ($)0.08|
|Day Range44.98–45.37||52-Week Range41.25–56.73|
As of Tue 01/27/2015 02:50 PM EST | USD
Novartis Upbeat Despite Weaker Profit -- Update
Research and Markets: Hot Drinks: Global Industry Almanac
Research and Markets: OTC Pharmaceuticals: Global Industry Guide 2014-2018: Market to value $170,812.0m by the end of 2018
Research and Markets: Global CINV Existing and Pipeline Drugs (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL and Rolapitant) Market 2014 - 2020
Reformulation of Marketed Drugs Expected to Boost the Epilepsy Market in the US by 2019: TechNavio
Novartis Completes Sale of Animal Health Division to Eli Lilly
The markets took a stream of negative news and weak economic growth indicators in stride during the first quarter.
We've found some intriguing U.K. investment opportunities.